Nasal Mist (0.9 % sodium chloride)
Nasal Decongestants Nasal Aerosol, Mist; Nasal Aerosol, Spray (Gram)
Last reviewed · Source: First Databank (FDB) drug data
Overview
USES: This product is used to treat dryness inside the nose (nasal passages). It helps add moisture inside the nose to dissolve and soften thick or crusty mucus. In babies and young children with stuffy noses who cannot blow their noses, using this product helps to make the mucus easier to remove with a nasal bulb syringe.
This helps relieve stuffiness and makes breathing easier. This product contains a purified gentle salt solution (also called saline or sodium chloride solution). It does not contain any medication.
Generic name: 0.9 % sodium chloride
Pronunciation: (SOE-dee-um KLOR-ide)
Drug class: Nasal Decongestants
Therapeutic class: Respiratory Therapy Agents
Reference product & biosimilars
No reference, biosimilar or interchangeable associated with this drug.
Today’s intelligence on Nasal Mist
Indications
The following indications are listed for Nasal Mist:
- Dry Nose
- Nasal Congestion
Also known as: Nasal Dryness, Nasal Stuffiness.
Dosing
No dosing information is available for this tab.
No dosing information is available for this tab.
No dosing information is available for this tab.
No dosing information is available for this tab.
Drug interactions
There is no enhanced messaging for this drug.
There are no contraindication interactions for this drug.
There are no severe interactions for this drug.
Moderate Interaction: Assess the risk to the patient and take action as needed.
Intranasal Decongestants/Zavegepant
SEVERITY LEVEL: 3-Moderate Interaction: Assess the risk to the patient and take action as needed.
MECHANISM OF ACTION: Intranasal decongestants may decrease the absorption of zavegepant.(1)
CLINICAL EFFECTS: Concurrent administration of intranasal decongestants may result in decreased systemic exposure and effectiveness of zavegepant.(1)
PREDISPOSING FACTORS: None determined.
PATIENT MANAGEMENT: Avoid concurrent use of intranasal decongestants with zavegepant. If concurrent use is unavoidable, use the decongestant at least 1 hour after zavegepant.(1)
DISCUSSION: Intranasal decongestants may lower absorption of zavegepant. This effect has not been clinically evaluated.(1)
Contraindications
There is no enhanced messaging for this drug.
There are no contraindication contraindications for this drug.
- Angle-closure glaucoma
- Benign prostatic hyperplasia
- Atherosclerotic cardiovascular disease
- Coronary artery disease
- Diabetes mellitus
- Hypertension
- Hyperthyroidism
Adverse reactions
There is no enhanced messaging for this drug.
Less Frequent
- Dizziness
- Headache disorder
- Insomnia
- Nervousness
- Rebound nasal congestion
- Tremor
Rare or Very Rare
- Cardiac arrhythmia
- Hypertension
Less Frequent
- Dry nose
- Nasal passage irritation
- Rhinorrhea
- Sneezing
Rare or Very Rare
- Nausea
- Palpitations
Precautions
No enhanced messaging available.
No enhanced messaging available.
No enhanced messaging available.
No enhanced messaging available.
No enhanced messaging available.
ICD codes
| Code | Type | Description |
|---|---|---|
| Dry nose | ||
| J34.89 | ICD10CM | Other specified disorders of nose and nasal sinuses |
| Nasal congestion | ||
| R09.81 | ICD10CM | Nasal congestion |
ICD code information from First Databank (FDB).
Formulary status
Search health-plan coverage for this drug by ZIP code.
Choose the first character of a health plan name.
Last reviewed · Source: First Databank (FDB) drug data
On this page
Actions
Sign in to save favorites
Saving this drug requires a free Physicians Office Resource account.